Sputnik V soft launched in over 50 cities in India, says Dr Reddy's

Photo for representational purpose

Dr Reddys Laboratories Ltd, which soft-launched Russia's Covid-19 vaccine, Sputnik V here on May 14 has expanded the pilot project to over 50 other cities and towns in the country.

In a tweet on Monday night, the city-based drugmaker said it will strengthen the commercial rollout of Sputnik V in the coming weeks.

"Starting initially in Hyderabad today, the soft launch rollout of Sputnik V has scaled up speedily and reached cities and towns all over India- including but not limited to Hyderabad, Vizag, Bengaluru, Mumbai, Navi Mumbai, Kolkata, Delhi, NCR, Chennai, Miryalaguda, Vijayawada, Baddi, Kolhapur, Kochi, Raipur, Chandigarh, Pune, Nagpur, Nashik it said in the tweet.

Recently, Dr Reddy's received nearly three million doses of SputnikV from Russian Direct Investment Fund with which it has a pact to sell 125 million people doses (250 million vials) in India. The Indian drug regulator has granted permission for restricted emergency use of SputnikV, developed by the Gamaleya National Research Institute of Epidemiology and Microbiology.

Dr Reddys has partnered with major hospitals across the country for this purpose all of whom have successfully administered Sputnik V in India including ongoing commercial rollouts to the public, the company added.

Also read: Dr Reddy's denied approval for Phase 3 trials of Sputnik Light Covid-19 vaccine

This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever.